These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 17408471)

  • 1. The atherogenic and metabolic impact of non-HDL cholesterol versus other lipid sub-components among non-diabetic and diabetic Saudis.
    Al-Daghri NM; Al-Attas OS; Al-Rubeaan K
    Lipids Health Dis; 2007 Apr; 6():9. PubMed ID: 17408471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid profile in patients with coronary artery disease.
    Haddad FH; Omari AA; Shamailah QM; Malkawi OM; Shehab AI; Mudabber HK; Shubaki MK
    Saudi Med J; 2002 Sep; 23(9):1054-8. PubMed ID: 12370711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperhomocysteinemia, coronary heart disease, and diabetes mellitus as predicted by various definitions for metabolic syndrome in a hypertensive Saudi population.
    Al-Daghri NM
    Saudi Med J; 2007 Mar; 28(3):339-46. PubMed ID: 17334456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A tertiary care hospital-based study of conventional risk factors including lipid profile in proven coronary artery disease.
    Goel PK; Bharti BB; Pandey CM; Singh U; Tewari S; Kapoor A; Garg N; Sinha N
    Indian Heart J; 2003; 55(3):234-40. PubMed ID: 14560932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.
    Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW
    Chin Med J (Engl); 2004 Feb; 117(2):163-7. PubMed ID: 14975195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between different lipoprotein fractions and the incidence of coronary heart disease in diabetics of Trinidad & Tobago.
    Ragoobirsingh D
    West Indian Med J; 1989 Mar; 38(1):42-7. PubMed ID: 2728434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Raising high-density lipoprotein cholesterol with reduction of cardiovascular risk: the role of nicotinic acid--a position paper developed by the European Consensus Panel on HDL-C.
    Chapman MJ; Assmann G; Fruchart JC; Shepherd J; Sirtori C;
    Curr Med Res Opin; 2004 Aug; 20(8):1253-68. PubMed ID: 15324528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Body fat mass distribution. Influence on metabolic and atherosclerotic parameters in non-insulin dependent diabetics and obese subjects with and without impaired glucose tolerance. Influence of weight reduction.
    Van Gaal L
    Verh K Acad Geneeskd Belg; 1989; 51(1):47-80. PubMed ID: 2800685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The lipid triad in type 2 diabetes - prevalence and relevance of hypertriglyceridaemia/low high-density lipoprotein syndrome in type 2 diabetes.
    Temelkova-Kurktschiev T; Hanefeld M
    Exp Clin Endocrinol Diabetes; 2004 Feb; 112(2):75-9. PubMed ID: 15031770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A cross-sectional study on the treatment goals of blood pressure, serum lipids and blood glucose in elderly patients with coronary heart disease].
    Zhu Y; Wang J; Bao Y; Qiao YX; Wu LZ; Li J; Li J; Hu DY
    Zhonghua Yi Xue Za Zhi; 2011 Jun; 91(21):1479-85. PubMed ID: 21914285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronary risk and dyslipidemia in type 2 diabetic patients.
    Udawat H; Goyal RK; Maheshwari S
    J Assoc Physicians India; 2001 Oct; 49():970-3. PubMed ID: 11848328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accuracy of lipoprotein lipids and apoproteins in predicting coronary heart disease in diabetic American Indians. The Strong Heart Study.
    Hu D; Jablonski KA; Sparling YH; Robbins DC; Lee ET; Welty TK; Howard BV
    Ann Epidemiol; 2002 Feb; 12(2):79-85. PubMed ID: 11880214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attainment of normal lipid levels among patients on lipid-modifying therapy in Hong Kong.
    Ambegaonkar B; Chirovsky D; Tse HF; Lau YK; Tomlinson B; Li SK; Yue CS; Wong TH; Choi MC; Tunggal P; Sazonov V
    Adv Ther; 2012 May; 29(5):427-41. PubMed ID: 22562782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-dialysis retention of blood lipoproteins and apolipoproteins in patients with end-stage renal disease on maintenance haemodialysis in Kuwait.
    Al-Rashidi M; Hussain AA; Nampoory MR; Al-Ali JH; Akanji AO
    Clin Chim Acta; 2004 Jun; 344(1-2):149-54. PubMed ID: 15149883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipids, diabetes, and coronary heart disease: insights from the Framingham Study.
    Kannel WB
    Am Heart J; 1985 Nov; 110(5):1100-7. PubMed ID: 4061265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lipid control in diabetic patients in Extremadura (Spain)].
    Roberto Robles N; Barroso S; Marcos G; Sánchez Muñoz-Torrero JF;
    Endocrinol Nutr; 2009 Mar; 56(3):112-7. PubMed ID: 19627723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triglyceride profile in dyslipidaemia of type 2 diabetes mellitus.
    Khan SR; Ayub N; Nawab S; Shamsi TS
    J Coll Physicians Surg Pak; 2008 May; 18(5):270-3. PubMed ID: 18541079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoproteins as predictors of ischemic heart disease in non-insulin-dependent diabetic men.
    Barrett-Connor E; Philippi T; Khaw KT
    Am J Prev Med; 1987; 3(4):206-10. PubMed ID: 3452358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of lipid and lipoprotein profiles in risk assessment and therapy.
    Ballantyne CM; Hoogeveen RC
    Am Heart J; 2003 Aug; 146(2):227-33. PubMed ID: 12891189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multivariate assessment of lipid parameters as predictors of coronary heart disease among postmenopausal women: potential implications for clinical guidelines.
    Shai I; Rimm EB; Hankinson SE; Curhan G; Manson JE; Rifai N; Stampfer MJ; Ma J
    Circulation; 2004 Nov; 110(18):2824-30. PubMed ID: 15492318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.